Evidence/Findings:
<p>Based on record review and interview, the manager failed to ensure a medication was administered to a resident in compliance with a medication order for two of six resident records reviewed. </p><p><br></p><p><br></p><p><br></p><p>Findings include:</p><p><br></p><p><br></p><p> </p><p>1. A review of R3's medical record revealed a service plan for directed care services, including medication administration.</p><p><br></p><p><br></p><p><br></p><p>2. A review of 3's medical record revealed a signed list of medications, dated February 23, 2025, which included the following medications:</p><p>- “AMLODIPINE BESYLATE 5MG TABLET… 1 TAB ORAL DAILY… 8AM”; and </p><p>- “SERTRALINE HCL 50MG TABLET… 2 TABLETS BY MOUTH AT BEDTIME – 8PM”.</p><p><br></p><p><br></p><p><br></p><p>3. A review of R3's medical record revealed an electronic Medication Administration Record (eMAR) dated May 2025. The eMAR documented the medications administered to R3 each day. However, the medications were administered late by more than one hour. Amlodipine Besylate was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 5, 2025, at 9:04 AM, May 10, 2025, at 10:59 AM, and May 13, 2025, at 9:07 AM. Sertraline HCL 50 mg was scheduled to be administered daily at 7:00 PM; however, it was administered late on May 2, 2025, at 8:28 PM, May 5, 2025, at 8:01 PM, and May 10, 2025, at 9:42 PM.</p><p><br></p><p><br></p><p><br></p><p>4. A review of R3’s medical record revealed a signed order for “MELOXICAM 15MG TABLET, Take 1 tab po q am”, which the facility scheduled at 8:00 AM daily. A review of R3’s eMAR revealed Meloxicam was scheduled to be administered at 8:00 AM; however, it was administered late on May 5, 2025, at 9:04 AM, May 10, 2025, at 10:59 AM, and May 13, 2025, at 9:07 AM.</p><p><br></p><p><br></p><p><br></p><p>5. A review of R4’s medical record revealed a service plan for personal care services, including medication administration.</p><p><br></p><p><br></p><p><br></p><p>6. A review of R4's medical record revealed a signed list of medications, dated April 22, 2025, which included the following medications:</p><p>- “Azelastine HCL Nasal Solution 137 MCG/SPRAY… 2 sprays into each nostril twice daily…”;</p><p>- “Cetirizine HCL Oral Tablet 10MG… 1 tablet by mouth once daily in the morning…”;</p><p>- “Latanoprost Ophthalmic Solution 0.005%... Administer 1 drop in each eye once daily in the evening…”;</p><p>- “Losartan Potassium Oral Tablet 25 MG… Give 1 tablet by mouth once daily in the morning…”;</p><p>- “Memantine HCL Oral Tablet 10 MG… Give 1 tablet by mouth once in the morning…”;</p><p>- “Montelukast Sodium Oral Tablet 10 MG… Give 1 tablet by mouth once daily in the morning…”;</p><p>- “Polyethylene Glycol 3350 Oral Powder 17 GM/SCOOP… Dissolve and drink 17 grams (1 scoop) in 8 oz of liquid once daily in the morning…”;</p><p>- “Senna Oral Tablet 8.6 MG… Give 1 tablet by mouth once daily at bedtime…”;</p><p>- “Symbicort Inhalation Aerosol 160-4.5 MCG/ACT… Inhale 2 puffs by mouth twice daily…”;</p><p>- “Tamsulosin HCL Oral Capsule 0.4 MG… Give 1 capsule by mouth once daily in the evening…”; and </p><p>- “Ventolin HFA inhalation Aerosol Solution 108 (90 Base) MCG/ACT…Inhale 2 puffs by mouth four times daily…”.</p><p><br></p><p><br></p><p><br></p><p>6. A review of R4's medical record revealed an eMAR dated May 2025. However, some medications were administered late by more than one hour. Azelastine HCL was scheduled to be administered daily at 8:00 AM and 7:00 PM; however, it was administered late on May 11, 2025, at 9:10 AM and on May 1, 2025, at 8:21 PM. Cetirizine HCL was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 11, 2025, at 9:10 am. Latanoprost was scheduled to be administered daily at 7:00 PM; however, it was administered late on May 1, 2025, at 8:21 pm. Losartan was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 11, 2025, at 9:10 AM. Memantine HCL was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 11, 2025, at 9:10 AM. Montelukast was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 11, 2025, at 9:10 AM. Polyethylene Glycol was scheduled to be administered daily at 8:00 AM; however, it was administered late on May 11, 2025, at 9:10 AM. Senna was scheduled to be administered daily at 7:00 PM; however, it was administered late on May 7, 2025, at 8:24 PM. Symbicort was scheduled to be administered daily at 8:00 AM and 7:00 PM; however, it was administered late on May 11, 2025, at 9:10 AM and on May 7, 2025, at 8:24 PM. Tamsulosin was scheduled to be administered daily at 7:00 PM; however, it was administered late on May 1, 2025, at 8:21 PM and May 7, 2025, at 8:24 PM. Ventolin HFA was scheduled to be administered daily at 8:00 AM, 12:00 PM, 4:00 PM, and 7:00 PM; however, it was administered late on May 11, 2025, at 9:10 AM, May 7, 2025, at 8:24 PM, and May 1, 2025, at 8:21 PM.</p><p><br></p><p><br></p><p><br></p><p>7. In an interview, E1 acknowledged some medications had been administered late and not as ordered for R3 and R4.</p>
Summary:
No deficiencies were found during the on-site investigation of complaints 00145021, 00145289, and 00145290 conducted on September 24, 2025.